Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Pneumococcal vaccine study for toddlers 12 to 15 months old

      We’re working closely with pediatricians and researchers to expand protection for toddlers against pneumococcal disease.

      22 trials found for Breast cancer, Breast Neoplasm

      All(22)
      Recruiting(20)
      Not yet recruiting(2)
      2 trials recruiting
      Pfizer Breast Cancer Clinical Trials

      Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

      Recruiting
      NCT06206837
      A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

      Breast Cancer

      Male or Female
      18+ years
      100study location(s)
      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      43study location(s)
      Recruiting
      NCT06157892
      A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

      Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast

      Male or Female
      18+ years
      38study location(s)
      Recruiting
      NCT05548127
      TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

      Breast Cancer

      Male or Female
      18+ years
      46study location(s)
      Recruiting
      NCT04767594
      First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

      Breast Neoplasms

      Male or Female
      18+ years
      193study location(s)
      Recruiting
      NCT06465368
      A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

      Breast Cancer

      Females
      18+ years
      10study location(s)
      Recruiting
      NCT05253911
      Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.

      HER2-positive Breast Cancer

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT06105632
      A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

      Advanced or Metastatic Breast Cancer

      Male or Female
      18+ years
      462study location(s)
      Recruiting
      NCT04557449
      Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

      Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

      Male or Female
      18+ years
      90study location(s)
      Recruiting
      NCT05748834
      Study of Tucatinib and Doxil in Participants with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

      Breast Cancer

      Male or Female
      18+ years
      6study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(22)
      Recruiting(20)
      Not yet recruiting(2)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.